Taxol phospholipid compound, pharmaceutical composition and use thereof

Disclosed are a taxol phospholipid compound, a pharmaceutical composition and a use thereof. In the invention, the pharmaceutical composition comprises a composition of the taxol phospholipid compound and a pharmacodynamically acceptable carrier, and is a liquid preparation, a solid preparation, a semi-solid preparation, a capsule, a granule, a gel or an injection. The pharmaceutical composition is a liposome nanoparticle prepared by using the taxol phospholipid compound and an adjuvant, and the particle size of the nanoparticle is 10-1000 nm.